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Acute post-stroke blood pressure relative to premorbid 
levels in intracerebral haemorrhage versus major 
ischaemic stroke: a population-based study
Urs Fischer*, Marie Therese Cooney*, Linda M Bull, Louise E Silver, John Chalmers, Craig S Anderson, Ziyah Mehta, Peter M Rothwell
Summary
Background It is often assumed that blood pressure increases acutely after major stroke, resulting in so-called post-
stroke hypertension. In view of evidence that the risks and beneﬁ ts of blood pressure-lowering treatment in acute 
stroke might diﬀ er between patients with major ischaemic stroke and those with primary intracerebral haemorrhage, 
we compared acute-phase and premorbid blood pressure levels in these two disorders.
Methods In a population-based study in Oxfordshire, UK, we recruited all patients presenting with stroke between 
April 1, 2002, and March 31, 2012. We compared all acute-phase post-event blood pressure readings with premorbid 
readings from 10-year primary care records in all patients with acute major ischaemic stroke (National Institutes of 
Health Stroke Scale >3) versus those with acute intracerebral haemorrhage.
Findings Of 653 consecutive eligible patients, premorbid and acute-phase blood pressure readings were available 
for 636 (97%) individuals. Premorbid blood pressure (total readings 13 244) had been measured on a median of 
17 separate occasions per patient (IQR 8–31). In patients with ischaemic stroke, the ﬁ rst acute-phase systolic blood 
pressure was much lower than after intracerebral haemorrhage (158·5 mm Hg [SD 30·1] vs 189·8 mm Hg [38·5], 
p<0·0001; for patients not on antihypertensive treatment 159·2 mm Hg [27·8] vs 193·4 mm Hg [37·4], p<0·0001), 
was little higher than premorbid levels (increase of 10·6 mm Hg vs 10-year mean premorbid level), and decreased 
only slightly during the ﬁ rst 24 h (mean decrease from <90 min to 24 h 13·6 mm Hg). By contrast with ﬁ ndings in 
ischaemic stroke, the mean ﬁ rst systolic blood pressure after intracerebral haemorrhage was substantially higher 
than premorbid levels (mean increase of 40·7 mm Hg, p<0·0001) and fell substantially in the ﬁ rst 24 h (mean 
decrease of 41·1 mm Hg; p=0·0007 for diﬀ erence from decrease in ischaemic stroke). Mean systolic blood pressure 
also increased steeply in the days and weeks before intracerebral haemorrhage (regression p<0·0001) but not before 
ischaemic stroke. Consequently, the ﬁ rst acute-phase blood pressure reading after primary intracerebral 
haemorrhage was more likely than after ischaemic stroke to be the highest ever recorded (OR 3·4, 95% CI 2·3–5·2, 
p<0·0001). In patients with intracerebral haemorrhage seen within 90 min, the highest systolic blood pressure 
within 3 h of onset was 50 mm Hg higher, on average, than the maximum premorbid level whereas that after 
ischaemic stroke was 5·2 mm Hg lower (p<0·0001).
Interpretation Our ﬁ ndings suggest that systolic blood pressure is substantially raised compared with usual premorbid 
levels after intracerebral haemorrhage, whereas acute-phase systolic blood pressure after major ischaemic stroke is 
much closer to the accustomed long-term premorbid level, providing a potential explanation for why the risks and 
beneﬁ ts of lowering blood pressure acutely after stroke might be expected to diﬀ er. 
Funding Wellcome Trust, Wolfson Foundation, UK Medical Research Council, Stroke Association, British Heart 
Foundation, National Institute for Health Research. 
Copyright © Rothwell et al. Open Access article distributed under the terms of CC BY.
Introduction
Blood pressure is increased in about 75% of patients with 
acute stroke (post-stroke hypertension) and usually 
decreases spontaneously over the subsequent few days.1–10 
Blood pressure in patients with acute stroke is higher 
than in those with other acute illnesses.2,7,11 However, a 
history of premorbid hypertension is also more common 
in patients with stroke than in otherwise healthy people,2,7 
and is associated with high post-stroke blood 
pressure1,2,4–6,8,9,12 and more variable blood pressure.13 Blood 
pressure is assumed to increase as a consequence of 
stroke, possibly due to disturbed autoregulation,14 
damage or compression of brain regions that regulate 
the autonomic nervous system,15 neuroendocrine 
factors,16–18 or as a consequence of headache,19 urine 
retention,14 infection,19 or the psychological stress of 
admission to hospital.6,12 However, to date, acute post-
stroke blood pressure levels have not been systematically 
compared with actual premorbid blood pressure levels.
The reduction of blood pressure after acute stroke has 
been shown to be either of no beneﬁ t or of slight harm 
in trials in predominantly ischaemic stroke,20–25 but to be 
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of some beneﬁ t in trials in primary intracerebral 
haemorrhage.26–28 However, the absence of a clear 
physiological rationale to explain this apparent 
diﬀ erence in eﬀ ect makes interpretation of the trial 
results diﬃ  cult. We and others have hypothesised that 
any beneﬁ ts of treatment to lower blood pressure in 
acute stroke might be greater in patients in whom a 
high post-event level is unaccustomed,29,30 and we have 
suggested that in some patients post-stroke hypertension 
might be due to a recent premorbid increase in blood 
pressure.31 To better understand the nature of acute 
post-stroke hypertension in intracerebral haemorrhage 
versus ischaemic stroke, we aimed to determine the 
relation between premorbid and acute post-event blood 
pressure in these two subtypes of stroke in the Oxford 
Vascular Study (OXVASC) study. 
Methods
Study design  and participants
Details of the study design have been previously 
described.32,33 Brieﬂ y, all patients presenting with stroke 
or transient ischaemic attack in Oxfordshire from 
April 1, 2002, to March 31, 2012, were recruited and 
followed up, irrespective of mode of presentation or 
referral (ie, emergency department, referred for direct 
admission to hospital, referred to clinic, or managed at 
home by the primary-care physician). Recruitment was 
achieved by several overlapping methods of daily hot 
and cold pursuit (appendix p 1), including prospective 
daily searches for acute events and retrospective 
searches of hospital and primary-care administrative 
and diagnostic coding data.32–34 As reported previously, 
more than 90% of patients were identiﬁ ed and assessed 
prospectively by hot pursuit,34 and overall case 
ascertainment is near-complete.32,33
All patients gave written informed consent; a relative 
of those who were unable to provide consent gave 
informed assent. OXVASC received ethics approval 
from participating ethics review committees.
Procedures  
Patients were assessed by a study clinician as soon as 
possible after the event and informed consent (or assent 
from a relative) was obtained. Clinical assessments and 
initial diagnoses were made by clinical fellows and 
reviewed by a stroke neurologist. We used standard 
deﬁ nitions of stroke.32 We recorded details of the 
presenting event by interviewing patients’ relatives and 
family practitioner, and by checking primary care and 
hospital records. We also recorded medication use 
before the event, previous vascular events, and vascular 
risk factors. We obtained detailed data for times and 
methods of ﬁ rst contact with medical attention after the 
event using a structured questionnaire. Time of 
symptom onset was the moment when symptoms were 
ﬁ rst noticed by the patient. When patients were found 
unconscious or aphasic, we took the time when they 
were last seen without symptoms as the start of the 
event. For symptoms present on waking, we took the 
time of waking as the time of symptom onset, but we 
also did sensitivity analyses excluding such cases.
We recorded the ﬁ rst post-stroke blood pressure 
measurement in the emergency department for all 
patients. If a patient was ﬁ rst seen by their family doctor, 
we obtained post-stroke blood pressure values and exact 
time of recording from their medical records or referral 
documentation. If patients were ﬁ rst assessed by 
paramedics outside a care setting, we obtained the ﬁ rst 
blood pressure recorded by the paramedics by 
systematically searching all relevant records in the 
ambulance service headquarters or using the copy of 
the ambulance sheet in the patient’s medical notes. In 
patients assessed hyperacutely (ﬁ rst blood pressure 
reading <90 min after symptom onset), we recorded all 
measurements during the ﬁ rst 24 h after the event.
We assessed the severity of neurological deﬁ cit with 
the National Institutes of Health Stroke Scale (NIHSS) 
score.35 Patients routinely underwent CT or MRI, carotid 
Doppler scanning, and electrocardiography, and had an 
echocardiogram when necessary. In view of the high 
rate (97%) of brain imaging or autopsy in OXVASC, and 
in keeping with our previous analyses,32,33 we coded 
strokes of unknown type as ischaemic.32 We used the 
TOAST (Trial of Org 10172 in Acute Stroke Treatment) 
criteria to classify strokes into cause subtypes.36
In accordance with European guidelines at the time of 
the study,37,38 blood pressure in the acute stage of the event 
was usually only lowered if systolic blood pressure 
exceeded 220 mm Hg or diastolic blood pressure exceeded 
120 mm Hg. We documented any new blood pressure-
lowering drug given within 24 h after the stroke. Any acute 
treatment was tailored to the individual, but usual policy 
was intravenous infusion of labetalol or nimodipine.
Study nurses reviewed life-long patient records held 
in primary care and extracted all premorbid blood 
pressure readings with dates in the 10 years before the 
event and the highest ever reading recorded in a 
standardised manner. We extracted data from both 
paper and computer records. Most readings had been 
taken in the doctor’s surgery by the physician or the 
practice nurse, either for screening purposes, regular 
review, or an episode of minor illness. Measurements 
made during previous hospital admissions, often for 
major illness, were not recorded. We also excluded 
measurements made in primary care at the time of any 
previous transient ischaemic attack or stroke.
Statistical analysis
We included all patients with primary intracerebral 
haemorrhage or major ischaemic stroke (NIHSS >3) who 
sought medical attention within 7 days after symptom 
onset. However, data for patients assessed hyperacutely 
(time from symptom onset to ﬁ rst blood pressure reading 
<90 min) and acutely (ﬁ rst reading <3 h after symptom 
See Online for appendix
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onset) were analysed separately. If a patient had more than 
one event within the study period, we included the ﬁ rst 
event. We excluded patients if their strokes occurred when 
in a country other than the UK and data were not available.
We excluded patients with transient ischaemic attack 
or minor stroke because such patients often seek medical 
care after a substantial delay, because previous 
randomised trials of acute blood pressure-lowering have 
focused on major stroke,20–28 and to avoid a major disparity 
in the severity of ischaemic events versus intracerebral 
haemorrhage.
Using the data extracted from primary care records, we 
established the most recent premorbid blood pressure, the 
10-year mean premorbid blood pressure, and the highest 
ever (maximum) premorbid blood pressure in patients 
with ischaemic stroke versus those in patients with 
primary intracerebral haemorrhage. We also established 
premorbid visit-to-visit variability of systolic blood pressure 
expressed as standard deviation (SD), coeﬃ  cient of 
variation (CV), and variation independent of mean (VIM), 
as described previously.39 We identiﬁ ed any evidence of a 
systematic rise in blood pressure during the year before 
the stroke using regression analysis of the most recent 
premorbid blood pressure versus the log of the time from 
blood pressure measurement to stroke, stratiﬁ ed by stroke 
type. We repeated this analysis using the following blood 
pressure parameters: most recent recording minus 
second-most recent reading, most recent recording minus 
maximum reading, and most recent recording minus 
10-year mean reading. We used the log of time from blood 
pressure reading to stroke because any premorbid 
increases in blood pressure before stroke were expected to 
cluster in the days and weeks immediately before the 
event.31
We compared the ﬁ rst post-event blood pressure with 
the most recent premorbid blood pressure, 10-year mean 
premorbid blood pressure, and the maximum premorbid 
blood pressure in patients with ischaemic stroke versus 
those in patients with intracerebral haemorrhage. Analyses 
were repeated by TOAST classiﬁ cation for ischaemic 
stroke and location (lobar or deep posterior) for 
intracerebral haemorrhage, by history of previous 
hypertension and by prior use of antihypertensives.
We compared pre-event and post-event readings using a 
paired t test. We used a Z test to test whether the 
percentage of post-event blood pressure readings greater 
than premorbid blood pressure readings was signiﬁ cantly 
diﬀ erent from 50%. We assessed diﬀ erences in post-
stroke blood pressure in subgroups with unpaired t tests 
or analysis of variance for continuous variables, and 
Fisher’s two-tailed test for categorical variables. The 
population distributions of measures of blood pressure 
were represented graphically by kernel density estimates, 
which estimate the smoothed frequency distribution of 
measurements
In patients who presented within 90 min of stroke onset, 
we analysed blood pressure trends over the subsequent 
24 h. A regression line with patients as a random eﬀ ect 
was ﬁ tted to estimate a random regression coeﬃ  cient. We 
did this separately for patients with intracerebral 
haemorrhage and for those with major ischaemic stroke, 
excluding patients who received any additional blood 
pressure-lowering treatment.
We also compared the ﬁ rst post-event blood pressure 
with the most recent and the maximum pre-event 
readings in the Oxford Community Stroke Project 
(OCSP), a population-based study in the same 
population in Oxfordshire, UK, between 1981 and 1986. 
The methods of OCSP are described elsewhere.40 OCSP 
used similar methods of case ascertainment and 
premorbid blood pressure collection to OXVASC, but 
 Major 
ischaemic stroke
(N=523)
Intracerebral 
haemorrhage 
(N=113)
p value
Mean age, years (SD) 78·7 (11·0) 75·9 (12·7) 0·02
Men 228 (44%) 60 (53%) 0·08
Diabetes 76 (15%) 11 (10%) 0·23
Smoking 0·95
Never 269 (51%) 57 (50%) ··
Ex-smoker 205 (39%) 46 (41%) ··
Current smoker 49 (9%) 10 (9%) ··
Previous hypertension 352 (67%) 67 (59%) 0·13
Previous atrial ﬁ brillation 169 (32%) 23 (20%) 0·01
Previous myocardial infarction 84 (16%) 6 (5%) 0·002
Previous angina 107 (20%) 12 (11%) 0·016
Previous transient ischaemic attack 75 (14%) 16 (14%) 1·00
Previous stroke 98 (19%) 11 (10%) 0·02
Previous peripheral vascular disease 58 (11%) 7 (6%) 0·17
Medication
Prior antihypertensives 352 (67%) 54 (48%) 0·0001
Prior statin 144 (28%) 23 (20%) 0·13
Prior antiplatelet therapy 258 (49%) 33 (29%) 0·0001
Number of premorbid BP readings
Mean (SD) 21·2 (16·7) 19·2 (15·0) 0·26
Median (IQR) 17 (8–31) 16 (7–32) 0·32
Stroke cause (TOAST subtype)
Large artery disease 37 (7%) ·· ··
Cardioembolic 211 (40%) ·· ··
Small artery disease 48 (9%) ·· ··
Other determined cause 15 (3%) ·· ··
Undetermined cause 77 (15%) ·· ··
Unknown cause 120 (23%) ·· ··
More than one cause 15 (3%) ·· ··
Location of intracerebral haemorrhage
Lobar ·· 45 (40%) ··
Deep or posterior ·· 66 (58%) ··
Both lobar and deep ·· 1 (1%) ··
Unknown ·· 1 (1%) ··
Data are n (%) unless otherwise speciﬁ ed. BP=blood pressure. TOAST=Trial of Org 10172 in Acute Stroke Treatment.
Table 1: Baseline demographic and clinical characteristics
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the ﬁ rst post-event blood pressure recorded was that 
measured when the patient was ﬁ rst seen by the study 
neurologist rather than at the ﬁ rst contact with medical 
or paramedical services. We used SPSS (version 20) for 
statistical analyses.
Role of funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication. 
Results
Of potentially eligible patients with stroke (n=734), 12 did 
not seek medical attention within 7 days, 12 were not 
referred to secondary care and had no acute blood pressure 
recorded, 16 died before any recording, 20 had their event 
in another country, and seven had it during cardiac arrest, 
inotropic support, or anaesthesia. A further 14 patients had 
intracerebral haemorrhage due to tumour, arteriovenous 
malformation, or another non-primary cause, leaving 
653 patients with initial NIHSS >3, of whom 636 (97%) 
had premorbid readings. Diﬀ erences in baseline 
demographic and clinical characteristics between patients 
with intracerebral haemorrhage and those with ischaemic 
stroke were as expected (table 1; appendix p 2).
Premorbid blood pressure (total readings 13 244) had 
been measured on a median of 17 separate occasions 
per patient (IQR 8–31). The number of premorbid 
readings was similar for intracerebral haemorrhage and 
ischaemic stroke (table 1), as was the distribution of 
time from most recent reading to stroke onset 
(appendix p 3). We noted a positive correlation between 
the number of premorbid readings and the mean 
premorbid systolic blood pressure (appendix p 4), with 
the association present in both intracerebral 
haemorrhage and ischaemic stroke.
The 10-year mean premorbid systolic blood pressure 
was much the same for patients with ischaemic stroke 
and those with intracerebral haemorrhage (table 2), but 
maximum premorbid systolic blood pressure was 
higher in patients with ischaemic stroke than in those 
with intracerebral haemorrhage (mean diﬀ erence 
6·5 mm Hg, 95% CI 0·5–12·4; p=0·03; table 2), as was 
premorbid visit-to-visit variability (SD 16·89 mm Hg vs 
15·13 mm Hg, p=0·01; CV 11·29% vs 10·11%, p=0·006; 
VIM 11·42 vs 9·96, p=0·0004).
Whereas the most recent premorbid systolic blood 
pressure in patients with ischaemic stroke was no greater 
in the period immediately before the stroke, systolic 
blood pressure was higher in the weeks and days before 
intracerebral haemorrhage (p<0·0001), especially in 
patients with deep or posterior bleeds (ﬁ gure 1). We saw 
the same temporal pattern for the diﬀ erence between the 
most recent and second-most recent systolic blood 
pressure (ie, the most recent premorbid rise on repeated 
measurements) and for the most recent premorbid 
Patients assessed within 3 h All patients
 n Maximum 
premorbid
(mm Hg)
10-year mean 
premorbid
(mm Hg)
Most recent 
premorbid 
(mm Hg)
First post 
event
(mm Hg)
n Maximum 
premorbid 
(mm Hg)
10-year mean 
premorbid 
(mm Hg)
Most recent 
premorbid
(mm Hg)
First post 
event 
(mm Hg)
Ischaemic stroke 294 179·7 (28·6) 147·9 (15·2) 140·6 (20·5) 158·5 (30·1) 523 180·9 (29·6) 148·6 (15·8) 140·8 (21·3) 158·1 (30·5)
Intracerebral haemorrhage 68 177·7 (26·1) 149·1 (17·9) 146·3 (22·5) 189·8 (38·5) 113 174·5 (27·2) 147·7 (17·7) 143·9 (22·1) 182·8 (37·6)
No previous hypertension
Ischaemic stroke 94 158·4 (21·8) 140·4 (14·0) 133·8 (17·9) 150·3 (28·1) 171 160·5 (23·1) 140·2 (14·1) 135·2 (18·1) 151·3 (29·8)
Intracerebral haemorrhage 23 161·7 (23·4) 140·2 (14·9) 142·2 (18·8) 191·4 (35·8) 46 157·4 (24·4) 138·8 (16·1) 139·5 (16·9) 176·5 (36·2)
Previous hypertension
Ischaemic stroke 200 189·7 (25·9) 151·1 (14·7) 143·8 (20·9) 162·3 (30·4) 352 190·9 (27·1) 152·3 (15·1) 143·5 (22·1) 161·4 (30·4)
Intracerebral haemorrhage 45 186·0 (23·7) 153·2 (17·8) 148·4 (24·1) 189·0 (40·1) 67 186·1 (22·5) 153·1 (16·5) 147·0 (24·6) 187·1 (38·2)
Location of intracerebral haemorrhage
Lobar 26 164·1 (21·9) 140·6 (16·0) 142·5 (20·1) 178·5 (32·0) 45 164·8 (24·7) 142·5 (16·5) 141·6 (19·0) 174·5 (34·2)
Deep or posterior 40 186·7 (25·6) 154·8 (17·5) 149·4 (24·2) 193·8 (38·9) 66 181·0 (27·4) 151·3 (18·0) 145·8 (24·1) 186·2 (37·3)
TOAST subtype
Cardioembolic 132 180·4 (29·1) 148·3 (15·5) 140·5 (21·4) 159·5 (30·2) 211 183·1 (29·7) 148·7 (15·7) 139·1 (21·5) 159·0 (31·0)
Large artery 26 186·3 (26·4) 148·7 (13·7) 141·0 (23·5) 154·6 (26·6) 37 186·4 (26·7) 150·5 (14·8) 145·8 (26·6) 160·9 (28·8)
Small vessel 14 170·6 (26·5) 146·8 (16·6) 145·6 (29·2) 173·3 (33·8) 48 175·7 (28·5) 148·6 (17·7) 146·7 (23·8) 169·4 (27·3)
Undetermined 40 175·0 (30·5) 145·8 (17·9) 139·4 (17·1) 152·5 (30·4) 77 179·2 (30·0) 148·1 (17·7) 141·0 (17·4) 157·7 (29·1)
Unknown 64 183·7 (24·9) 149·7 (12·2) 141·4 (18·3) 160·3 (31·2) 120 180·4 (29·3) 148·9 (14·1) 139·9 (20·5) 153·1 (32·8)
More than one cause 8 168·5 (30·2) 138·3 (16·4) 129·1 (14·2) 150·5 (25·4) 15 176·9 (28·5) 142·6 (14·8) 137·1 (21·0) 147·9 (21·6)
Other known cause 10 167·7 (39·4) 147·3 (21·0) 141·7 (18·8) 152·4 (24·6) 15 170·4 (36·8) 147·7 (18·6) 142·1 (16·3) 154·3 (23·8)
Data are mean (SD). TOAST=Trial of Org 10172 in Acute Stroke Treatment.
Table 2: Systolic blood pressure, measured before and immediately after event, by stroke subtypes
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systolic blood pressure versus the 10-year mean systolic 
blood pressure and the maximum premorbid systolic 
blood pressure (ﬁ gure 1).
The median interval from stroke onset to ﬁ rst blood 
pressure measurement was 2·0 h (IQR 0·7–7·0) after 
intracerebral haemorrhage and 2·3 h (0·7–11·6) after 
ischaemic stroke. The ﬁ rst post-event blood pressure 
reading was done by a primary care physician for 51 (8%) 
patients, by paramedics or ambulance personnel in 
337 (53%) patients, by emergency department personnel 
in 172 (27%) patients, and by others in 76 (12%) patients, 
with no diﬀ erence between intracerebral haemorrhage 
and major ischaemic stroke (p=0·76). We detected no 
correlation between the ﬁ rst post-event systolic blood 
pressure and ﬁ rst NIHSS score in patients with 
intracerebral haemorrhage (r=0·02, p=0·85) or in those 
with ischaemic stroke (r=–0·02, p=0·67).
For blood pressure measured within 3 h of stroke 
onset, mean ﬁ rst systolic blood pressure after 
intracerebral haemorrhage was higher than the most 
recent premorbid reading (average increase 
43·5 mm Hg, p<0·0001; tables 2 and 3, ﬁ gure 2). The 
ﬁ rst systolic blood pressure after ischaemic stroke was 
lower than that after intracerebral haemorrhage 
(p<0·0001) and only a little higher than premorbid 
levels (a 17·9 mm Hg increase vs most-recent systolic 
blood pressure and a 10·6 mm Hg increase vs 10-year 
mean premorbid level; table 2, ﬁ gure 2). Findings were 
similar in patients whose ﬁ rst measurement was taken 
more than 3 h after an event, on analysis excluding 
wake-up strokes, and on analysis restricted to patients 
with a ﬁ rst blood pressure reading within 6 h of stroke 
and at least two premorbid measurements within the 
previous 12 months (appendix pp 5–6). The diﬀ erences 
in acute systolic blood pressure between intracerebral 
haemorrhage and ischaemic stroke were greatest in 
patients assessed within minutes of onset; mean post-
event systolic blood pressure decreased with time from 
event after intracerebral haemorrhage, but not after 
ischaemic stroke (table 3).
Although premorbid systolic blood pressure rose before 
intracerebral haemorrhage (ﬁ gure 1), the additional 
Figure 1: Temporal trends in premorbid systolic blood pressure measurements in relation to the time of stroke
Most-recent systolic blood pressure (SBP; A), diﬀ erence between most-recent and second-most-recent premorbid SBP (B), diﬀ erence between most-recent and maximum 
premorbid SBP (C), and diﬀ erence between most-recent and 10-year mean premorbid SBP (D). The lines and associated equations are derived from a log-linear regression. 
ICH=intracerebral haemorrhage. 
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Patients with deep or posterior intracerebral haemorrhage
Patients with lobar intracerebral haemorrhage
Patients with ischaemic stroke
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increase from the most recent premorbid blood pressure 
reading to the ﬁ rst post-event reading was no less in 
patients with very recent premorbid readings than in 
those with readings taken a longer period before the event 
(p=0·63 for regression of increment vs time since 
reading). In other words, the high post-event systolic 
blood pressure in intracerebral haemorrhage was due to 
both a rise in systolic blood pressure premorbidly and a 
subsequent additional increase in systolic blood pressure 
from the last premorbid reading that was greater than 
that seen in ischaemic stroke, in which there was no 
premorbid increase and only a small post-event increase.
Figure 2 shows the relative distributions of the most 
recent premorbid systolic blood pressure and the ﬁ rst 
post-event systolic blood pressure. The ﬁ rst post-event 
systolic blood pressure was higher than the 10-year 
average premorbid systolic blood pressure in only 304 
(58%) of 523 patients with ischaemic stroke compared 
with 96 (85%) of 113 patients with intracerebral 
haemorrhage (p<0·0001). Figure 3 shows a comparison 
of the distribution of the ﬁ rst post-event systolic blood 
pressure with the maximum premorbid systolic blood 
pressure. 385 (74%) patients with ischaemic stroke had at 
least one higher oﬃ  ce reading (reading in primary care) 
in the past. The ﬁ rst post-event systolic blood pressure 
exceeded the maximum pre-event level in only 63 (28%) 
of 229 patients with severe ischaemic stroke (NIHSS 
>10). By contrast, the ﬁ rst post-event systolic blood 
pressure reading was higher than the maximum-ever 
premorbid level in 62 (55%) of 113 patients with primary 
intracerebral haemorrhage. Results were similar for 
diastolic blood pressure (data not shown).
Because a patient’s ﬁ rst post-event systolic blood 
pressure might not be their highest acute-phase systolic 
blood pressure, in those patients who were assessed 
within 90 min of stroke we compared the highest post-
event systolic blood pressure reading measured within 
3 h of symptom onset with the maximum premorbid 
blood pressure (ﬁ gure 4). Maximum pre-event and post-
event systolic blood pressure were similar after ischaemic 
stroke (mean 180·6 mm Hg vs 175·4 mm Hg, mean 
diﬀ erence 5·2, 95% CI –1·2 to 11·6, p=0·16), but the 
average post-event maximum was substantially greater 
after primary intracerebral haemorrhage (217·6 mm Hg 
0–15 min 15–30 min 30–90 min 90 min to 3 h 3–12 h 12–24 h >24 h
Mean post-event SBP (mm Hg)
Intracerebral haemorrhage 204·4 (31·5); 8 192·0 (47·4); 18 188·9 (34·6); 25 181·9 (37·5); 17 173·8 (33·1); 24 172·0 (29·3); 11 168·7 (43·3); 10
Ischaemic stroke 155·0 (29·2); 42 156·0 (29·7); 54 159·6 (30·9); 119 160·4 (30·0); 79 156·5 (31·5); 103 157·9 (30·5); 50 158·8 (31·1); 76
Mean increase in post-event SBP compared with most-recent premorbid SBP (mm Hg)
Intracerebral haemorrhage 46·0 (45·8); 8 47·5 (48·0); 18 44·1 (30·3); 25 37·1 (34·4); 17 36·9 (36·8); 24 26·5 (37·0); 11 25·9 (31·3); 10
Ischaemic stroke 11·8 (29·5); 42 20·6 (30·4); 54 18·6 (31·3); 119 18·2 (31·4); 79 19·3 (31·9); 103 13·1 (39·1); 50 15·3 (27·0); 76
Data are mean (SD); n. SBP=systolic blood pressure.
 Table 3: Relation between time to assessment and mean systolic blood pressure before and after event 
Figure 2: Distribution of most recent premorbid systolic blood pressure and ﬁ rst post-event systolic blood pressure
(A) Ischaemic stroke. (B) Intracerebral haemorrhage.
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vs 177·6 mm Hg, mean diﬀ erence 50·0, 38·1 to 61·8, 
p<0·0001). We detected no diﬀ erence between 
intracerebral haemorrhage and ischaemic stroke in the 
timing of measurements in the ﬁ rst 24 h after stroke 
(appendix p 7).
The extent to which the ﬁ rst post-event systolic blood 
pressure exceeded premorbid levels is shown in table 4. 
The ﬁ rst acute-phase blood pressure was more likely to 
be the highest ever recorded in patients with primary 
intracerebral haemorrhage than in those with ischaemic 
stroke (OR 3·4, 95% CI 2·3–5·2, p<0·0001) and to be 
more than 40 mm Hg higher than the most recent 
premorbid reading (3·7, 2·4–5·6, p<0·0001) or the 
10-year average (4·4, 2·8–7·1, p<0·0001), for primary 
intracerebral haemorrhage versus ischaemic stroke.
Diﬀ erences between ischaemic stroke and primary 
intracerebral haemorrhage in post-event systolic blood 
pressure were independent of a previous diagnosis of 
hypertension (table 2) and use of antihypertensive drugs 
(appendix p 8). Of ischaemic strokes categorised by the 
TOAST criteria, patients with small-vessel events had 
the highest mean post-event systolic blood pressure 
Figure 3: Distribution of maximum premorbid systolic blood pressure and ﬁ rst post-event systolic blood pressure in all patients
(A) Ischaemic stroke. (B) Intracerebral haemorrhage.
Figure 4: Distribution of maximum premorbid systolic blood pressure and maximum systolic blood pressure within 3 h after the event in patients presenting 
within 90 min of stroke onset
(A) Ischaemic stroke. (B) Intracerebral haemorrhage.
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(table 2) and the greatest increase in the acute phase 
compared with mean premorbid systolic blood pressure 
(22·7 mm Hg). Similar diﬀ erences were seen for deep 
or posterior intracerebral haemorrhage versus lobar 
bleeds (table 2).
All systolic blood pressure readings in the ﬁ rst 24 h in 
patients who presented within 90 min of onset are given 
in the appendix. Systolic blood pressure decreased more 
rapidly (p=0·0007) after primary intracerebral 
haemorrhage (decrease 1·7 mm Hg per h, 41·4 mm Hg 
in 24 h) than after ischaemic stroke (0·56 mm Hg per h, 
13·6 mm Hg in 24 h). In these analyses, we excluded 
data for six patients with primary intracerebral 
haemorrhage who received additional blood pressure-
lowering treatment within 24 h. The ﬁ ndings were 
unchanged in an additional analysis after exclusion of 
data for patients who died within the ﬁ rst 24 h.
We tested some of our ﬁ ndings on data from the 
Oxfordshire Stroke Community Project (OSCP), in which 
65 patients had primary intracerebral haemorrhage and 
294 had major ischaemic stroke (deﬁ ned by modiﬁ ed 
Rankin Scale >2 at 1 month in the absence of baseline 
NIHSS scores). The time from stroke onset to ﬁ rst 
examination by the study neurologist was missing or was 
more than 7 days in 111 patients (22 with primary 
intracerebral haemorrhage, 89 with ischaemic stroke). Of 
the remaining 248 patients (appendix p 10), 219 (38 with 
primary intracerebral haemorrhage, 181 with ischaemic 
stroke) had their premorbid blood pressure recorded in 
primary care. Although the median time from stroke onset 
to blood pressure recording by the study neurologist was 
2 days (IQR 0–4), diﬀ erences between ischaemic stroke 
and primary intracerebral haemorrhage in OSCP were 
similar to those in our study. The mean ﬁ rst post-event 
systolic blood pressure was higher than the most recent 
pre-event level in patients with primary intracerebral 
haemorrhage (178·8 mm Hg [SD 33·6] vs 161·4 mm Hg 
[23·2]; p=0·0037) and was similar to the maximum 
premorbid systolic blood pressure (185·1 mm Hg [31·3]; 
p=0·30). However, the mean ﬁ rst post-event systolic blood 
pressure after ischaemic stroke was no higher than the 
most recent premorbid systolic blood pressure 
(156·5 mm Hg [29·2] vs 156·4 mm Hg [29·7]; p=0·97) and 
was lower than the mean maximum-recorded premorbid 
systolic blood pressure (184·4 mm Hg [35·1]; p<0·0001).
Discussion
In patients with intracerebral haemorrhage in our study, 
blood pressure was substantially increased after stroke 
compared with usual premorbid levels. This increase 
was due both to a rise in premorbid systolic blood 
pressure in the days and weeks before the event and to a 
subsequent additional increase in systolic blood pressure 
from the last premorbid reading that was greater than 
that seen after ischaemic stroke. In patients with 
ischaemic stroke, acute post-event systolic blood pressure 
was much closer to the premorbid levels to which these 
patients were presumably accustomed, with no rise in 
systolic blood pressure before the event and only a small 
post-event increase. Consequently, in the ﬁ rst 24 h after 
stroke, blood pressure decreased much more after 
intracerebral haemorrhage than after ischaemic stroke.
To the best of our knowledge, this is the ﬁ rst 
prospective, population-based study of acute post-stroke 
hypertension and the ﬁ rst study to compare post-stroke 
readings with detailed premorbid blood pressure data 
(panel). Long-term hypertension is a major risk factor 
for primary intracerebral haemorrhage, accelerating 
small-vessel disease and increasing the risk of rupture.41 
However, primary intracerebral haemorrhage can also 
occur during hypertensive crises and after major stress 
associated with short-term increase in blood pressure,42,43 
suggesting that, in at least some patients, acute post-
stroke hypertension might partly reﬂ ect a recent, 
premorbid increase in blood pressure. Our ﬁ ndings 
substantiate this notion, but suggest that post-stroke 
Most-recent premorbid SBP 10-year average premorbid SBP Maximum premorbid SBP
Odds ratio 
(95% CI)
Intracerebral 
haemorrhage 
(n)
Ischaemic 
stroke (n)
Odds ratio 
(95% CI)
Intracerebral 
haemorrhage 
(n)
Ischaemic 
stroke (n)
Odds ratio 
(95% CI)
Intracerebral 
haemorrhage 
(n)
Ischaemic 
stroke (n)
≤0 mm Hg increase 
(reference group)
1·0 (0·5–2·1) 19 153 1·0 (0·5–2·2) 16 192 1·0 (0·6–1·5) 51 385
0–20 mm Hg 
increase
1·1 (0·5–2·4) 18 128 2·7 (1·3–5·7) 26 114 1·9 (1·0–3·3) 21 85
21–40 mm Hg 
increase
1·2 (0·6–2·5) 20 132 1·9 (0·9–4·1) 18 114 3·5 (1·7–7·3) 15 32
41–60 mm Hg 
increase
3·4 (1·7–6·8) 30 71 5·5 (2·5–12·0) 22 48 5·8 (2·4–13·4) 13 17
>60 mm Hg 
increase
5·4 (2·5–11·3) 26 39 11·1 (5·0–25·0) 26 28 24·5 (7·1–105·8) 13 4
Proportions of intracerebral haemorrhage versus ischaemic stroke stratiﬁ ed according to the increase between the ﬁ rst post-event SBP and premorbid levels. Numbers for 
10-year average premorbid SBP do not add to total because data are for only patients with at least two measures of SBP during the past 10 years. SBP=systolic blood pressure.
 Table 4: Increase in systolic blood pressure after stroke in comparison with three measures of premorbid blood pressure control in intracerebral 
haemorrhage versus ischaemic stroke
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factors also contribute to acute post-stroke hypertension, 
the ﬁ rst post-stroke blood pressure being higher than 
the most recent premorbid blood pressure even in 
patients with a recent pre-event rise. Intracerebral 
haemorrhage often causes acutely increased intracranial 
pressure,41 which would raise blood pressure via the 
Cushing reﬂ ex,44 and an increase in blood pressure of 
20–60 mm Hg is seen during major psychological 
stress,31 which most probably also contributes to post-
stroke levels. Indeed, it is surprising, therefore, that the 
increase in blood pressure over premorbid levels after 
ischaemic stroke is so limited, with most patients having 
had higher readings in the doctor’s surgery in the past.
The distribution of blood pressures in the acute phase 
in patients with ischaemic stroke was broader than the 
distribution of the most recent readings (ﬁ gure 2), and 
visit-to-visit variability in premorbid blood pressure was 
higher than in primary intracerebral haemorrhage, 
which is perhaps consistent with evidence that transient 
peaks and troughs in blood pressure can cause ischaemic 
stroke.31,42,43,45,46 Post-stroke blood pressure in patients 
with ischaemic stroke, however, seemed to mainly reﬂ ect 
longer-standing premorbid levels. The possible 
exceptions were patients with small-vessel ischaemic 
stroke, who had higher post-event levels than those with 
ischaemic stroke of other causes, which is consistent 
with previous ﬁ ndings,6,7 and had a greater increase in 
systolic blood pressure compared with recent premorbid 
levels (small vessel stroke was the only subtype in which 
post-event blood pressure was similar to maximum 
premorbid levels). We saw similar associations for deep 
or posterior versus lobar primary intracerebral 
haemorrhage, which is also consistent with the 
hypothesis that hypertension is a particularly important 
risk factor for disease of the small perforating vessels.
Our ﬁ ndings have implications for interpretation of 
studies of acute blood pressure after stroke, particularly 
for apparent relations with outcome in observational 
studies without data on premorbid blood pressure 
levels.47–49 They also provide a potential physiological 
rationale to explain why the eﬀ ects of acute blood 
pressure-lowering might diﬀ er in intracerebral 
haemorrhage 26–28 versus major ischaemic stroke.20–25 The 
absence of beneﬁ t and possible harm associated with 
acute blood pressure-lowering in ischaemic stroke might 
be related to reduction of blood pressure to a level to 
which a patient is unaccustomed. In accustomed 
hypertension, the cerebral perfusion curve is shifted to 
the right,50 such that rapid blood pressure-lowering could 
compromise blood ﬂ ow at a time when perfusion is 
already acutely compromised. Indeed, subgroup analyses 
in the SCAST trial24 suggested that blood pressure-
lowering was harmful in patients with pre-existing 
hypertension, and blood pressure-lowering in 
INTERACT II28 also tended to be less eﬀ ective in those 
with known prior hypertension. However, not all trials 
have shown this trend,25 and some uncertainty still 
remains as to the role of post-stroke blood pressure in 
early outcome. Our ﬁ ndings do, nevertheless, draw 
attention to the importance of consistent long-term 
control of blood pressure, especially in prevention of 
intracerebral haemorrhage, for which sustained increases 
in blood pressure for a short period seem to be a trigger
Our study has some limitations. First, late presentation 
might have led to underestimation of the hyper-acute 
post-stroke blood pressure levels. However, we also did 
most analyses in patients presenting within 90 min and 
3 h of the event and saw similar results to those in the 
overall analysis, and more ﬁ nely stratiﬁ ed analyses 
(table 3) showed that diﬀ erences between intracerebral 
haemorrhage and ischaemic stroke were greatest in the 
hyper-acute period. Second, post-stroke use of 
antihypertensive drugs might have aﬀ ected our analysis 
of the post-stroke decrease in blood pressure levels. 
However, acute treatment was very rare and our analysis 
of the timecourse of post-stroke blood pressure excluded 
the few treated patients. Third, the accuracy of blood 
pressure readings can be aﬀ ected by measurement error. 
However, observer error in nurses and physicians in 
blood pressure measurements has an SD of about 
5 mm Hg and could not account for the diﬀ erence we 
saw between intracerebral haemorrhage and ischaemic 
stroke. Fourth, a systematic protocol for recording of 
premorbid blood pressure was not possible, and we had 
to rely on measurements made in routine clinical 
practice in primary care. However, because our primary 
aim was to compare ischaemic stroke and intracerebral 
haemorrhage, for which the number and timing of 
premorbid measurements were very similar, this study 
limitation should not have introduced any bias. 
Moreover, most patients were older than 65 years, the 
Panel: Research in context
Systematic review
We searched Medline and Embase up to Oct 20, 2013, using 
the search terms “post-stroke hypertension” and “blood 
pressure in acute stroke”. We also reviewed the reference lists 
of retrieved studies for relevant papers. We restricted our 
search to studies done in human beings. We applied no 
language restrictions. Several studies have shown that blood 
pressure is often high immediately after stroke and that it 
usually decreases over the subsequent few days, irrespective 
of treatment. However, we identiﬁ ed no study that had 
compared post-stroke blood pressure with premorbid levels.
Interpretation
Our ﬁ nding that blood pressure is raised compared with usual 
premorbid levels after intracerebral haemorrhage but not 
after major ischaemic stroke provides a potential explanation 
for why the risks and beneﬁ t of lowering blood pressure 
acutely after stroke might be expected to diﬀ er between 
intracerebral haemorrhage and major ischaemic stroke.
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age at which routine annual screening measurements of 
blood pressure are done in UK primary care, so that 
readings would be fairly standardised. Indeed, the extent 
of visit-to-visit variability in blood pressure is similar to 
that reported in previous randomised controlled trials.39,51 
Finally, we excluded patients with transient ischaemic 
attack or minor stroke, in whom acute-phase blood 
pressure might be higher than in those with major 
stroke. However, inclusion of these mainly ischaemic 
events would have introduced a severity bias in our 
comparison with intracerebral haemorrhage and would 
have made our study population very diﬀ erent to that 
included in previous randomised controlled trials of 
blood pressure-lowering in acute stroke.20–28
Our ﬁ ndings provide a potential rationale for why the 
risks and beneﬁ t of lowering blood pressure acutely after 
stroke might be expected to diﬀ er between intracerebral 
haemorrhage and major ischaemic stroke and have 
implications for design of future trials, which should 
take account of premorbid blood pressure in eligibility 
criteria and analyses. Our ﬁ ndings also draw attention to 
the need for consistent control of blood pressure in 
prevention of intracerebral haemorrhage. 
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